Navigation Links
Vitamin D deficiency associated with reduced lung function
Date:1/31/2011

VITAMIN D DEFICIENCY ASSOCIATED WITH REDUCED LUNG FUNCTION

New research shows that vitamin D deficiency is prevalent among patients with interstitial lung disease (ILD), with the largest prevalence seen in patients with concurrent connective tissue disease (CTD). Researchers from the University of Cincinnati College of Medicine evaluated vitamin D levels in 67 patients with CTD-ILD and 51 patients with other forms of ILD. Results showed the overall prevalence of vitamin D deficiency and insufficiency was 38 percent and 59 percent, respectively. Those with CTD-ILD were more likely to have vitamin D deficiency (52 percent vs 20 percent) and insufficiency (79 percent vs 31 percent) than other forms of ILD. Among patients with CTD-ILD, reduced vitamin D levels were strongly associated with reduced lung function. Researchers conclude that vitamin D may have a role in the pathogenesis of CTD-ILD. This article is published in the February issue of Chest, the peer-reviewed journal of the American College of Chest Physicians: Chest 2011; 139(2):353-360.

INFLUENZA A(H1N1) MORTALITY NOT INCREASED BY OBESITY

New research suggests that obesity may not influence mortality rates among patients with influenza A(H1N1); however obese patients with the virus may have longer ICU and hospital stays. Researchers from Spain compared mortality rates and hospital/ICU resource consumption between 150 obese patients with influenza A(H1N1) and 266 patients with influenza A(H1N1) who were not obese. Results showed that obese patients were supported by mechanical ventilation longer and had longer ICU and hospital lengths of stay than patients who were not obese. However, after adjusting for severity and potential confounding variables, obesity was not associated with ICU mortality. The article is published in the February issue of Chest, the peer-reviewed journal of the American College of Chest Physicians: Chest 2011; 139(2):382-386.

CYSTEINE A POTENTIAL BIOMARKER FOR SLEEP APNEA

A new study indicates that the amino acid cysteine may be a biomarker for the development of obstructive sleep apnea (OSA) in obese and nonobese patients. Brazilian researchers compared plasma levels of cysteine in 75 patients with OSA with 75 control subjects. Results showed that cysteine plasma levels were higher in patients with OSA compared with the control subjects. A subgroup of lean patients (BMI < 25) with OSA also had higher cysteine levels than the control subjects. Furthermore, patients with OSA who received continuous positive airway pressure showed a decrease in plasma levels of cysteine after 6 months. Researchers conclude that cysteine is a potential biomarker for OSA and that obesity does not influence its function as a biomarker. The article is published in the February issue of Chest, the peer-reviewed journal of the American College of Chest Physicians: Chest 2011; 139(2):246-252.


'/>"/>

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians
Source:Eurekalert

Related biology news :

1. Dont forget the vitamin A when working with its carrier protein
2. Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
3. Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist
4. Lack of vitamin D linked to Parkinsons disease
5. Vitamin K does not stem BMD decline in postmenopausal women with osteopenia
6. Optimal dose of vitamin E maximizes benefits, minimizes risk
7. Lung airway cells activate vitamin D and increase immune response
8. Could vitamin D save us from radiation?
9. Vitamin C lowers levels of inflammation biomarker considered predictor of heart disease
10. Vitamin D found to fight placental infection
11. Calcium and vitamin D may not be the only protection against bone loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... 2016 On Monday, the Department of Homeland ... share solutions for the Biometric Exit Program. The Request ... Protection (CBP), explains that CBP intends to add biometrics ... the United States , in order to deter ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... Axovant Sciences Ltd. (NYSE: AXON ... treatment of dementia, today announced that data on the ... disease will be presented at the 2016 Clinical Trials ... 2016 in San Diego . Intepirdine ... and complex measures of activities of daily living (ADLs) ...
(Date:12/5/2016)... 5, 2016 According to ... by Products (Consumable, Instruments, Automated Cell Expansion System), ... Stem Cell Research, Cancer, and Cell-Based Research), End-users ... - Global Revenue, Trends, Growth, Share, Size and ... the global cell expansion market is expected to ...
(Date:12/5/2016)... Research and Markets has announced the addition of Jain ... Companies" to their offering. ... , , ... development of sequencing technologies, and their applications. Current large and ... Various applications of sequencing are described including those for genetics, ...
(Date:12/4/2016)... CAMBRIDGE, Mass. and ... 4, 2016 SystemOne, a company focused ... platforms for the developing world, and Daktari Diagnostics, ... reality with its portable and ultrasensitive immunoassay-based CarePlatform™, ... development and license agreement to integrate Daktari,s technology ...
Breaking Biology Technology: